Quality Improvement for Institutions
www.cvquality.acc.org

Practice Guidance for Registry Participants in Medicaid Meaningful Use

Quality Payment Program

In 2017, the Advancing Care Information (ACI) Performance category replaced the Medicare Electronic Health Record (EHR) Incentive Program, also known as Meaningful Use (MU). All eligible professionals who previously participated in the EHR Incentive Program should click here to verify their eligibility under the Quality Payment Program (QPP). The Quality Payment Program did not replace Medicaid Meaningful Use and participants can still use the PINNACLE Registry® and Diabetes Registry Collaborative® to meet those program requirements.

Medicaid EHR Incentive Program

The Medicaid EHR is administered voluntarily by state and territories and is separate from QPP requirements. Eligible hospitals and eligible professionals (EP) that participate in the Medicaid EHR Incentive Program attest directly to the state. To view a list of the available Medicaid EHR states and websites, click here. Participants can choose to report under Modified Stage 2 objectives and measures or Stage 3 objectives and measures regardless of location.

The PINNACLE and Diabetes Collaborative Registries are both considered specialized registries for the Modified Stage 2 Specialized Registry Reporting and Stage 3 Clinical Data Registry Reporting measure.

Modified Stage 2 requires EPs to attest to at least three measures from the Public Health Reporting measures. Measure options include:

  1. Immunization Registry Reporting: The eligible hospital or CAH is in active engagement with a public health agency to submit immunization data.
  2. Syndromic Surveillance Reporting: The eligible hospital or CAH is in active engagement with a public health agency to submit syndromic surveillance data.
  3. Specialized Registry Reporting: The eligible hospital or CAH is in active engagement to submit data to a specialized registry.
  4. Electronic Reportable Laboratory Result Reporting: The eligible hospital or CAH is in active engagement with a public health agency to submit electronic reportable laboratory (ELR) results.

There are three ways to achieve active engagement for Modified Stage 2 Objectives:

  • Option 1: The MU program participant has registered with a Public Health Agency (PHA) or Clinical Data Registry (CDR) within 60 days after the start of the EHR reporting period and is awaiting an invitation from the PHA or CDR to begin testing and validation.
  • Option 2: The MU program participant is in the process of testing and validation of the electronic submission of data.
  • Option 3: The MU program participant has completed testing and is electronically submitting production data.

To access full Public Health Reporting Modified Stage 2 Objectives and Measures click here.

Stage 3 requires EPs to actively engage with a Public Health Agency (PHA) or clinical data registry (CDR) to submit electronic public health data in a meaningful way using Certified Electronic Health Record Technology (CEHRT), except where prohibited and in accordance with applicable law and practice. Measure options include:

  • Immunization Registry Reporting: The EP is in active engagement with a public health agency to submit immunization data and receive immunization forecasts and histories from the public health immunization registry/immunization information system (IIS).
  • Syndromic Surveillance Reporting: The EP is in active engagement with a public health agency to submit syndromic surveillance data from an urgent care setting.
  • Electronic Case Reporting: The EP is in active engagement with a public health agency to submit case reporting of reportable conditions.
  • Public Health Registry Reporting: The EP is in active engagement with a public health agency to submit data to public health registries.
  • Clinical Data Registry Reporting: The EP is in active engagement to submit data to a clinical data registry.

There are three ways to achieve active engagement for Stage 3 Objectives:

  • Option 1: The MU program participant has registered with a Public Health Agency (PHA) or Clinical Data Registry (CDR) within 60 days after the start of the EHR reporting period and is awaiting an invitation from the PHA or CDR to begin testing and validation.
  • Option 2: The MU program participant is in the process of testing and validation of the electronic submission of data.
  • Option 3: The MU program participant has completed testing and is electronically submitting production data.

To access full Public Health and Clinical Data Registry Reporting Stage 3 Objectives and Measures click here.


Temp Styles

American College of Cardiology: 2400 N St. NW, Washington DC 20006